fr

Medscape

Medscape InDiscussion: Myelofibrosis

Listen to Medscape InDiscussion: Myelofibrosis, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999593. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Auteur

Medscape

Catégorie

Science

Site du podcast

www.medscape.com

Dernier épisode

10 juil. 2025

Où écouter ?

Les podcasts dans l'appli Replaio Radio Bientôt disponible

Les podcasts arrivent très bientôt dans l'appli. Installe-la dès maintenant et découvre en avant-première une toute nouvelle façon de vivre les podcasts

Télécharger sur Google Play Installe-la gratuitement Android près de 10 M de téléchargements · note de 4,8 iOS bientôt

Épisodes

S2 Episode 6: A Futuristic Vision for Treating Myelofibrosis 10.07.2025

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier interventions, and smarter diagnostics. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002058. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only...

S2 Episode 5: Posttransplant Monitoring in Myelofibrosis 10.06.2025

Join Drs Tania Jain and Rachel Salit as they explore evolving definitions of remission, relapse monitoring, and patient-centered transplant decisions in myelofibrosis care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002057. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast i...

S2 Episode 4: JAK Inhibitors: Too Many Choices or Not Enough? 08.05.2025

Join Drs Tania Jain and Prithviraj Bose as they discuss the available JAK inhibitors and how they use them to treat myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002056. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professi...

S2 Episode 3: Can We Prevent Myelofibrosis? The New Interferon Era 08.04.2025

Join Drs Tania Jain and Brandi Reeves as they discuss primary myelofibrosis and post-ET (essential thrombocythemia) and post-PV (polycythemia vera) myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002055. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended...

S2 Episode 2: Diet, Exercise, and Myelofibrosis: A Holistic Approach 06.03.2025

Join Drs Tania Jain and Krisstina Gowin as they discuss the role integrative medicine plays in the treatment of myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002054. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professional...

S2 Episode 1: What's Next? Clinical Trials in Myelofibrosis 06.03.2025

Drs Tania Jain and Ruben Mesa discuss the clinical trials and the future of myelofibrosis research. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/1002053. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Myeloprolifera...

S1 Episode 6: What Does the Future Look Like for Myelofibrosis? 06.11.2024

Join Drs Tania Jain and Gabriela Hobbs as they discuss their views on the future of research and patient care in myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999598. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professional...

S1 Episode 5: Transplant Tips, Talks, and Timing for Myelofibrosis 03.10.2024

Join Drs Tania Jain and Jeanne Palmer as they discuss their approach to transplant in myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999597. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Myelofibrosis...

S1 Episode 4: Myelofibrosis: Considering TP53 and Post-MPN AML 05.09.2024

Join Drs Tania Jain and Raajit Rampal as they discuss TP53, post-MPN AML, and high-risk MPNs in the context of myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999596. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals....

S1 Episode 3: What's Your Approach? Treating Myelofibrosis 07.08.2024

Join Drs Tania Jain and Lindsay Rein as they discuss the current treatment landscape and their approach to treating patients with myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999595. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US health...

S1 Episode 2: What's Next? Promising Trials and Therapeutics in Myelofibrosis 03.07.2024

Join Drs Tania Jain and Aaron Gerds as they discuss the latest developments in clinical trials and investigational therapeutics for MPNs. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999594. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare pr...

S1 Episode 1: Risk Stratification in Myelofibrosis: Which Model Should You Use? 03.07.2024

Join Drs Tania Jain and Pankit Vachhani as they discuss the nuance involved in the risk stratification of myelofibrosis and the latest research in prefibrotic myelofibrosis. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/999593. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast i...

Écoute le podcast Medscape InDiscussion: Myelofibrosis sur Replaio

La radio et les podcasts dans une seule appli - gratuite, sans inscription. Installe-la dès aujourd'hui et ne rate pas le lancement

Télécharger sur Google Play

Replaio n'est pas éditeur de podcasts ; les noms des émissions, les visuels et l'audio appartiennent à leurs auteurs et sont diffusés via des flux RSS publics